Bipolar disorder (BD) is a severe and chronic mental disorder, and patients experience multiple relapses. 1 Major depressive disorder (MDD) is the most common mental disorder, with a prevalence that is up to 3.02% in China, 4.45% in the USA, and 22.5% in Afghanistan according to the World Health Organization. 2 Many investigators have reported broad and persistent cognitive deficits in patients with mood disorders overall, and these include BD and MDD. 3, 4 A systematic review of cognitive dysfunction in patients with BD indicated deficits in most cognitive domains. 5 Another study reported that patients with BD were subject to multiple cognitive deficits, especially in attention, executive functioning, verbal memory, and fluency. 6 Decline in cognitive performance was also observed in MDD patients, 7 with impairment in most domains. 8 A study from the year 2000 claimed that the cognitive impairment of euthymic patients with BD was similar to that of patients with unipolar depressive disorders. 9 Another study reported that deficits of cognitive function in MDD patients were similar to those of BD patients during a depressive episode, 10 and a 12-month prospective study showed that the cognitive performance of depressed patients with either MDD or BD was comparable. 11 These studies were in accord with another longitudinal, naturalistic study. 12 Yet, studies comparing the cognitive functions of BD and MDD patients have not been consistent. The definition of cognitive impairment also affected the results of deficits among patients with BD or MDD. 13 For example, it has been reported that patients with BD were more impaired, across all domains, compared with patients with MDD. 14 In another recent systematic review, patients with BD were more cognitively impaired than MDD patients with regard to verbal memory, but not in the domains of attention, processing speed, executive functions, or theory of mind. 15 According to another study, the BD group had more impaired patients than did the group with depression. 16 Recently, a meta-analysis reported that MDD and BD patients demonstrated similar cognitive performances during depressive episodes, and verbal memory was better in MDD during euthymia. 17 Some studies have explored whether cognitive impairments exist in the first-degree relatives (FDR) of patients with mood disorders. One study reported cognitive deficits in the unaffected siblings of BD patients. 18 A literature review of studies regarding the unaffected atrisk relatives of BD patients found that these individuals had a higher rate of cognitive deficits in verbal memory and executive function than did the general population. 19 A recent review again showed cognitive deficits in a population of relatives of BD patients compared with a healthy control (HC) group, but the affected domains differed from those of the patients. 20 Accordingly, some functional magnetic resonance imaging studies demonstrated deficits in several brain regions and structural brain networks in non-affected first-degree relatives. 21, 22 Among healthy individuals at heritable risk for mood disorders, poor performance in cognitive function was shown to be a risk factor of affective illness onset. 23 A new systematic review and metaanalysis suggested that cognitive dysfunction predicted subsequent episodes of MDD. 24 There have been many robust studies in cognitive research regarding BD and MDD, and others have considered the FDR of patients with mood disorders. However, no single study has compared the cognitive functions of both BD and MDD patients and their FDR with an HC group. Therefore, the present study compared the cognitive functions of patients with BD or MDD, unaffected FDR, and HC individuals using a mixed model.
Methods Participants
This was a cross-sectional study conducted at Beijing Anding Hospital (China). The clinical research ethics committee of Beijing Anding Hospital approved the study protocols. All participants were enrolled from September 2014 to September 2016. Suitable patients for the study were adults with a diagnosis of BD or MDD based on the DSM-IV who were euthymic or depressive. Diagnoses were made using the Structured Clinical Interview for DSM-IV Axis I Disorders -Patient Edition (SCID-I/P). 25, 26 The FDR (children or siblings of BD or MDD patients) and HC individuals recruited for this study had no history of psychiatric or cognitive disorders.
The inclusion criteria for the study population were as follows: aged 18-55 years inclusive; ≥9 years of formal education; Young Mania Rating Scale (YMRS) total scores ≤ 6; and signed an informed written consent. Individuals with any of the following were excluded: history of dementia or mental retardation and brain injuries; modified electric convulsive therapy within the recent 3 months; psychosis caused by a general medical condition; severe suicidal thoughts or attempts; or a major chronic medical or neurological condition.
Assessments
Assessments of the study population were conducted by qualified psychiatrist raters who underwent training, prior to the beginning of the study, in the use of the assessment scales.
Repeatable Battery for the Assessment of Neuropsychological Status
Assessments of neurocognitive performance were performed using the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). 27 RBANS has been translated into multiple languages and validated in several countries, [28] [29] [30] including China. 31 The good reliability and validity of the Chinese version of the RBANS has been demonstrated. The Cronbach's α coefficient of the RBANS total scale was 0.90; the Cronbach's α coefficients of the Immediate Memory, Visuospatial, Language, Attention, and Delayed Memory subscales were 0.86, 0.68, 0.67, 0.85, and 0.80, respectively. The test-retest reliability of the total scale was 0.90 and those of the subscales were 0.65, 0.68, 0.53, 0.80, and 0.79, respectively. The RBANS is easily performed and requires almost 30 min to administer. The raw scores of the cognitive tests were corrected, based on sex and age, using the RBANS table, and converted to scaled scores for the five cognitive domains (below), which were then used in subsequent analyses. A total score of RBANS was provided with a mean AE SD value of~100 AE 15.
The RBANS consists of the following five domains (12 tests): Attention (digital span, coding); Language (picture naming, semantic fluency); Visuospatial/constructional (figure copy, line orientation); Immediate memory (list learning, story memory); and Delayed memory (list recall, list recognition, story recall, figure recall). The raw scores of each domain were summed to yield a total score that represents overall cognitive function.
Wechsler Adult Intelligence Scale
The Chinese version 32 of the Wechsler Adult Intelligence Scale, 33 revised short form, was applied to evaluate IQ, which included four subsets: Information, Similarities, Picture Completion, and Block Design. All correlation coefficients (r) between this brief version and the full version are at a high level, and most of them are above 0.9. The total scores of the full version and brief version were consistent in the same sample, and the differences were not significant.
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Demographics and mood status assessments
The patients' basic sociodemographic and clinical data were collected using a questionnaire designed for the study. Mood status was assessed using the YMRS, 35 the Hamilton Depression Scale (HAM-D), 36 and the Hamilton Anxiety Scale (HAM-A). 37 
Statistical analysis
The data were analyzed using SAS 9.2 for Windows (SAS Institute, Cary, NC, USA). Comparisons were performed using Pearson's χ 2 -tests for categorical variables, and one-way analysis of variance (ANOVA) for continuous variables, as appropriate. Covariance adjusted for individual demographic variables and clinical characteristics was also estimated among the study groups. The level of significance was set at 0.05 (2-tailed). A Hochberg adjustment for multiple comparisons was used to perform post-hoc pairwise comparisons of betweengroup differences. 38 Cognitive impairment was measured using four different approaches. First, the mean group scores were analyzed by ANOVA, the traditional analysis method. Second, the percentage of patients who fell ≥2 SD below the mean cut-off score (i.e., <70, considered clinically meaningful impairment) was calculated. Cognitive performance was investigated in the number of domains in which individuals scored <70. Frequencies of impaired cognitive domains (i.e., ≥2 SD below the mean) obtained through χ 2 -tests have been proposed, with the intention to develop a homogeneous comparison index and attenuate the placebo response rate. 16 Third, the effect sizes were also calculated for each two-group comparison. Some studies have chosen effect size as the evaluation strategy to differentiate levels of cognitive deficits. 39 Values over 0.8 are considered to represent a high effect size, while values ranging from 0.5 to 0.8 and from 0.2 to 0.5 represent medium and small effect sizes, respectively. Finally, cognitive impairment was measured using a mixed model that included fixed covariates for individual background variables and clinical characteristics, which was used to explore the variance of RBANS results among the four study groups with a random intercept model. The model distribution of the response variable was continuous with the scores of RBANS. Furthermore, multinomial regression analyses with groups as dependent variable and cognitive deficits, IQ, year, education, sex, and psychopathology as independent variables were also conducted.
Results

Demographic and clinical characteristics
Initially, 414 individuals were screened for the study, and 20 were excluded (Fig. 1) . Finally, the study population comprised of 105 patients with BD I (59 euthymic patients), 109 patients with MDD (49 euthymic patients), 85 unaffected FDR (49 siblings, 36 offspring), and 95 HC. The mean ages varied among the four groups. The total scores of the YMRS, HAM-D, and HAM-A scales were significantly different among the four groups (Table 1) .
Cognitive performance and frequency of clinically meaningful impairment
In an ANOVA, a comparison of the four groups revealed significant differences in overall RBANS scores, and in the domains of Immediate Memory, Language, Attention, and Delayed Memory (Table 2 ). In an analysis of covariance for demographic and IQ variables, the differences among the groups remained significant with regard to Language (F = 4.61, P < 0.001), Delayed Memory (F = 3.69, P = 0.012), and RBANS total scores (F = 4.83, P = 0.003).
Only 7.4% of the HC individuals fell below a score of 70 on two or more cognitive domains, but these percentages were 10.2%, 18.8%, and 19.8% in the FDR, MDD, and BD groups, respectively ( Table 3 ). The distributions of frequency of impaired domains were significantly different (Fig. 2, χ 2 = 15.94, P = 0.014). Pairwise comparisons of frequencies of impaired domains indicated significant differences between the BD or MDD and HC groups (Table 4) .
Post-hoc analyses and effect size of pairwise comparisons for RBANS Post-hoc pairwise comparisons of the above ANOVA were performed using a Hochberg adjustment (Table 4) . Except for the visuospatial domain, patients with BD or MDD performed worse in the other four domains and the total RBANS score compared with the HC individuals. Patients with BD also performed more poorly in language, delayed memory, and the total RBANS score, compared with the FDR. However, the FDR and HC participants were similar in all domains, and the total RBANS score.
The effect size of the RBANS index and total RBANS scores of every combination of two groups were calculated ( 
Cognitive function across all domains and related factors
An analysis of the cognitive function of participants using the mixed model indicated significant variation in the four groups across all domains. The mean score of cognitive performance was highest in the HC group, and then decreased from FDR to MDD to BD (greatest; F = 32.74, P < 0.001; Fig. 3 ). Cognitive deficits were associated with age (F = 32.74, P < 0.001). When IQ was included as a variable (F = 240.63, P < 0.001), the significance of age disappeared (F = 0.28, P = 0.599). Years of education also had a positive effect on cognitive performance (F = 17.04, P < 0.001). When age at onset or duration of illness was included, the group differences were attenuated (F = 0.09, P = 0.771). The total HAM-D score was positively associated with the severity of cognitive deficits (F = 5.78, P = 0.017).
Multinomial regression analyses
In the multinomial regression analyses with groups as dependent variable and RBANS total score, IQ score, age, education years, sex, HAM-D total score, and HAM-A total score as independent variable, RBANS total score (χ 2 = 10.76, P = 0.001) and HAM-D total score (χ 2 = 58.13, P < 0.001) were associated with the dependent variable.
Discussion
This study compared the cognitive function of BD patients, MDD patients, unaffected FDR, and HC individuals using a mixed model. We found that the BD patients suffered the most severe cognitive deficits, followed by the MDD patients, and then the FDR. The strengths of the paper are the relatively large sample size and the ability to compare the three groups against HC in a single study. Some studies have compared the cognitive functions of BD and MDD patients and reported that these groups were similar in deficits, 11, 40, 41 but in general it seems that cognitive dysfunction is greater in patients with BD. 42 In another study, the FDR (siblings) of BD patients exhibited significant deficits compared with an HC group for the cognitive domains Executive Function and Vigilance. 43 In the present mixed model, based on all five domains and total scores, the cognitive function of the study groups ranked, from low to high, as: BD, MDD, FDR, and HC. The cognitive deficits were similar, but varied in degree; cognitive deficits were more severe in the BD than the MDD patients. The FDR group displayed cognitive deficits and their performance fell between that of the HC and patient groups. The differences between the BD group and relatives were identified in Language and Delayed Memory (Table 4) , which has not been reported before. The mixed model is an exploratory attempt to handle this kind of data, to better reveal the actual trends in cognitive dysfunction in different populations. The mixed model included all domains and reflects overall cognitive function. The mixed model amplified the importance of these differences among the four groups. In the cognitive domains of Language and Delayed Memory, the results were a medium effect size between the BD patients and HC individuals, while the overall cognitive function was a high effect size. The effect sizes ranged from low to medium between the MDD patients and HC individuals. However, low effect sizes were gained between BD and MDD, MDD and FDR, and FDR and HC. Reports of the mean for a group may obscure the heterogeneity of the group, since the cognitive dysfunction can range from none to severe. In clinical practice it is generally useful to categorize patients who are ≥2 SD below the mean as cognitively impaired, 16 which is a more strict criteria. The percentages of the groups with impaired domains that fell ≥2 SD below the mean score were significantly different between the BD (or MDD) and HC groups. The prevalence of cognitive deficits in the present sample of BD patients was about the same as the MDD group, but less than that of the FDR. Participants within the same group were diverse in terms of cognitive function. Additional in-depth studies are needed that focus on patients who are clinically impaired in cognitive function, and differences between cognitively impaired patients and patients with normal cognitive function.
In the mixed model, we found that the differences among the study groups in cognitive performance assessed by RBANS were attenuated after adjusting for age, age at onset, and duration of illness. Age had an effect on cognitive performance resulting from IQ differences. The age at onset was earlier for BD patients, compared with MDD patients, and duration of illness was longer. Earlier illness onset and longer episode duration correlated with cognitive dysfunction. 44 A meta-analysis investigated the association between depression severity and cognitive function, and indicated that depression severity correlated with the cognitive domains Episodic Memory, Executive Function, and Processing Speed. 45 In a later long-term study that evaluated cognitive dysfunction and clinical symptoms, depressive symptoms correlated with poor cognitive function. 46 In accord with these previous findings, our study found that more severe depressive symptoms were associated with heavier cognitive deficits in the entire population. In the multinomial regression analyses, cognitive performance and HAM-D total scores were the predictors of different groups.
It is hard to establish a correlation between specific cognitive dysfunctions and specific psychiatric disorders, or to differentiate psychiatric disorders using a cognitive assessment, and we were not able to identify a cognitive domain that could be regarded as a trait of the population. The current results suggest that each of these populations had a range of cognitive deficits that varied in degree. In a previous systematic review, patients with schizophrenia exhibited cognitive impairment that was more severe and prevalent than BD patients. 47 The Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) Study tested a continuum model of cognitive dysfunction in psychotic disorders, which indicated that neuropsychological impairments were progressively greater from BD to schizoaffective disorder to schizophrenia. 48 We postulate that cognitive deficits are characteristics of psychiatric disorders in general, and are not specific to a single disorder. The degree of impairment varies within any specific neuropsychiatric disorder. Further studies are needed regarding diagnostic assessments of cognitive function.
The results of the present study must be interpreted with caution due to several limitations. First, the four study groups were not fully matched with regard to demographic characteristics, such as age and IQ. In analyses, these variables were corrected. Second, RBANS is the only tool used to assess cognitive performance, which is a relatively brief battery for cognition assessment. The cognitive function may be only partly revealed. However, the RBANS is a viable and well-standardized instrument that requires relatively little time and evaluates several aspects of cognitive function efficiently. Third, a majority of patients were receiving psychotropic drugs, and we cannot minimize the possible confounding effect of medications on cognitive function, because the usage of the various medications and combinations were complex. Therefore, the medication effect was not addressed. Finally, the sample of participants was not homogenous; both depressive and euthymic patients (not manic) were enrolled. Patients with BD had the most severe cognitive deficits, followed by patients with MDD, and then the FDR. We postulate that cognitive deficits are a characteristic of psychiatric disorders in general, with differences in degree in each. Further studies should acknowledge this important point in cognitively impaired patients with psychiatric disorders. 
